Synergistic in-vitro effects of combining an antiglycolytic, 3-bromopyruvate, and a bromodomain-4 inhibitor on U937 myeloid leukemia cells.
2018-05-31

2018. Kapp N, Stander XX, Stander BA. Anticancer Drugs 29(5): 429-439.